UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Osteoporosis international, 2017-03, Vol.28 (3), p.799-809

2017

Volltextzugriff (PDF)

One year outcomes and costs following a vertebral fracture

Osteoporosis international, 2005-01, Vol.16 (1), p.78-85

2005

Volltextzugriff (PDF)

The impact of teriparatide adherence and persistence on fracture outcomes

Osteoporosis international, 2012-03, Vol.23 (3), p.1103-1113

2012

Volltextzugriff (PDF)

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US

Osteoporosis international, 2011, Vol.22 (1), p.47-56

2011

Volltextzugriff (PDF)

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer

Bone (New York, N.Y.), 2010-11, Vol.47 (5), p.966-974

2010

Volltextzugriff (PDF)

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US

Osteoporosis international, 2011-10, Vol.22 (10), p.2611-2621

2011

Volltextzugriff (PDF)

Fracture Reduction Affects Medicare Economics (FRAME) : Impact of increased osteoporosis diagnosis and treatment

Osteoporosis international, 2005-12, Vol.16 (12), p.1545-1557

2005

Volltextzugriff (PDF)

Hospital care of osteoporosis-related vertebral fractures

Osteoporosis international, 2003, Vol.14 (1), p.53-60

2003

Volltextzugriff (PDF)

Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patients during a 52‐week, randomised, placebo‐controlled, phase 3 clinical trial

Journal of the European Academy of Dermatology and Venereology, 2022-04, Vol.36 (4), p.e277-e279

2022

Volltextzugriff (PDF)

FRAX and the effect of teriparatide on vertebral and non-vertebral fracture

Osteoporosis international, 2015-11, Vol.26 (11), p.2677-2684

2015

Volltextzugriff (PDF)

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Osteoporosis international, 2012-08, Vol.23 (8), p.2141-2150

2012

Volltextzugriff (PDF)

Teriparatide fracture effectiveness in the real world

Osteoporosis international, 2015-08, Vol.26 (8), p.2217-2218

2015

Volltextzugriff (PDF)

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

Patient preference and adherence, 2018-01, Vol.12, p.1483-1503

2018

Volltextzugriff (PDF)

EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease

Value in health, 2022-07, Vol.25 (7), p.S385

2022

Volltextzugriff (PDF)

Metabolic Disorders, Osteoporosis and Fracture Risk in Asia: A Systematic Review

Value in health, 2014-11, Vol.17 (7), p.A772-A772

2014

Volltextzugriff (PDF)

PSY36 - Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

Value in health, 2017-10, Vol.20 (9), p.A902-A902

2017

Volltextzugriff (PDF)

PSS36 - Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

Value in health, 2017-10, Vol.20 (9), p.A807-A807

2017

Volltextzugriff (PDF)

Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

Value in health, 2017-10, Vol.20 (9), p.A807

2017

Volltextzugriff (PDF)

Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

Value in health, 2017-10, Vol.20 (9), p.A902

2017

Volltextzugriff (PDF)

Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

Value in health, 2017-10, Vol.20 (9), p.A902

2017

Volltextzugriff (PDF)

PSY37 - Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

Value in health, 2017-10, Vol.20 (9), p.A902-A902

2017

Volltextzugriff (PDF)

Resource-based relative-value scale expansion: implications for performance and quality of care

Clinical performance and quality health care, 1997-01, Vol.5 (1), p.5

Burge, R T

1997

Volltextzugriff (PDF)

Economies of Scale in Physician Practice

Medical care research and review, 1996-12, Vol.53 (4), p.417-440

1996

Volltextzugriff (PDF)

Interstate Variation in the Burden of Fragility Fractures

Journal of bone and mineral research, 2009-04, Vol.24 (4), p.681-692

2009

Volltextzugriff (PDF)

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia

Patient preference and adherence, 2020-01, Vol.14, p.1049-1064

2020

Volltextzugriff (PDF)

1 – 25 von 1.577

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.321)
Mit Volltextzugriff
(1.291)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(883)
Life Sciences & Biomedicine
(670)
Humans
(483)
Female
(275)
Male
(260)
Biological And Medical Sciences
(255)
Medical Sciences
(188)
Adult
(169)
Middle Aged
(166)
Physical Sciences
(139)
Animals
(132)
Aged
(125)
Physics
(99)
Technology
(92)
General & Internal Medicine
(91)
Medicine, General & Internal
(75)
Fundamental And Applied Biological Sciences. Psychology
(71)
Dermatology
(66)
Endocrinology & Metabolism
(63)
Adolescent
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

One year outcomes and costs following a vertebral fracture

The impact of teriparatide adherence and persistence on fracture outcomes

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US

Fracture Reduction Affects Medicare Economics (FRAME) : Impact of increased osteoporosis diagnosis and treatment

Hospital care of osteoporosis-related vertebral fractures

Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patients during a 52‐week, randomised, placebo‐controlled, phase 3 clinical trial

FRAX and the effect of teriparatide on vertebral and non-vertebral fracture

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Teriparatide fracture effectiveness in the real world

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease

Metabolic Disorders, Osteoporosis and Fracture Risk in Asia: A Systematic Review

PSY36 - Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

PSS36 - Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

PSY37 - Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

Resource-based relative-value scale expansion: implications for performance and quality of care

Economies of Scale in Physician Practice

Interstate Variation in the Burden of Fragility Fractures

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia

Suchergebnisse filtern